Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
04/2000
04/13/2000WO2000002877A3 New pharmaceutically active compounds
04/13/2000WO1999029687A8 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
04/13/2000DE19845406A1 Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Substituted 1,3-diaryl-2-pyridin-2-yl-3- (pyridin-2-ylamino) - propanol derivatives, process for their preparation, pharmaceutical compositions containing them and their use
04/13/2000CA2346537A1 Monomeric and dimeric heterocycles, and therapeutic uses thereof
04/13/2000CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases
04/13/2000CA2341346A1 Non-peptide gnrh agents, methods and intermediates for their preparation
04/12/2000EP0992502A1 2-(3-Phenyl-2-propenyl)-1,2,3,4-tetrahydro-isochinolin derivatives, process for their preparation and their use as fungicides
04/12/2000EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists
04/12/2000EP0992492A1 Small molecule inhibitors of rotamase enzyme activity
04/12/2000EP0991753A1 Protease inhibitors
04/12/2000EP0991646A1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same
04/12/2000EP0991645A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
04/12/2000EP0991643A1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
04/12/2000EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES
04/12/2000EP0991623A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto
04/12/2000EP0991621A1 Novel heterocyclic compounds
04/12/2000EP0991620A1 Pyrrolidine carboxylic acid derivatives as endothelin antagonists
04/12/2000EP0991410A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates
04/12/2000EP0991408A1 Novel process for manufacturing paroxetine solid dispersions
04/12/2000EP0759917B1 Novel selective inhibitors of viral or bacterial neuraminidases
04/12/2000EP0655448B1 Benzopyran and benzoxazine derivatives
04/12/2000CN1250447A 4-(3-heterocyclyl-1-benzoyl) pyrazoles and their use as herbicides
04/12/2000CN1250446A Pyrazole derivatives as herbicides
04/12/2000CN1250441A Pesticidal 1-arylpyrazoles
04/12/2000CN1250440A Process for preparing pyrazole derivatives
04/12/2000CN1250051A New indane-1-alcohol compound, its preparation method and medical composition containing the same
04/12/2000CN1051298C Substituted cyclohexanolester, its use for treatment of disease and pharmaceutical agent
04/11/2000US6048983 Process for the preparation of benzopyran compounds
04/11/2000US6048893 Substituted phenyl compounds with a substituent having A 1,3-benzodioxole ring
04/11/2000US6048880 Therapy for cytokine sensitive diseases
04/11/2000US6048876 Anticonvulsants; antiepilepic agent
04/11/2000US6048875 Benzothiophene, benzofuran and indole compounds
04/11/2000US6048864 Benign prostatic hyperplasia
04/11/2000US6048823 Pyridone derivatives and herbicides
04/11/2000CA2082617C Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method
04/11/2000CA1340952C Chemiluminescent 1,2-dioxetane compounds
04/08/2000CA2285120A1 Heterocycles
04/06/2000WO2000018763A2 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
04/06/2000WO2000018761A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
04/06/2000WO2000018753A1 2-phenylpyran-4-one derivatives
04/06/2000WO2000018740A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
04/06/2000WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors
04/06/2000WO2000018723A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/06/2000WO2000018399A1 Preventive and/or therapeutic agents for sinusitis______________
04/06/2000WO2000018358A2 Method of treating hair loss using ketoamides
04/06/2000WO1999061013A3 COMPOUNDS HAVING IgE AFFECTING PROPERTIES
04/06/2000CA2345108A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/06/2000CA2340454A1 Benzamide derivatives and their use as cytokine derivatives
04/05/2000EP0990655A1 Method for drying anhydrous paroxetine hydrochloride
04/05/2000EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
04/05/2000EP0989983A1 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase
04/05/2000EP0989857A1 Novel therapeutic agents that modulate enzymatic processes
04/05/2000EP0989851A1 Self-emulsifying formulation for acidic lipophilic compounds
04/05/2000EP0844825A4 Insecticidal n-(substituted arylmethyl)-4- bis(substituted phenyl or pyridyl)methyl]piperidines
04/05/2000EP0740791A4 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties
04/05/2000CN1249751A Substd. 2,4-diaminopyrimidines
04/05/2000CN1249749A Phthalazinones
04/05/2000CN1249748A Small molecules useful in treatment of inflamatory disease
04/05/2000CN1249682A Use of angiotension II antagonists to treat symptomatic heart failure
04/05/2000CN1051085C Substed. dihydropyranopyridines, their preparation process, use and pharmaceutical composition contg. same
04/05/2000CN1051079C Benzodiazepine derivs. their preparation method and pharmaceutical composition contg. same
04/04/2000US6046355 Dihydropyrones with improved antiviral activity
04/04/2000US6046331 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
04/04/2000US6046327 Phosphate-mediated cyclization
04/04/2000US6046227 Useful in the treatment of type ii diabetes and obesity; a substituted pyrazine compound
04/04/2000US6046226 Administering to a patient an anti cryptococcus neoformans using dicationic bis/benzimidazole compounds; antifungal agents
04/04/2000US6046218 Pyridine derivative and medicament containing the same as an effective ingredient
04/04/2000US6046213 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives
04/04/2000US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors
04/04/2000US6046208 Treatment of rheumatoid arthritis, osteoarthritis, endotoxemia and/or toxic shock syndrome, other acute or chronic inflammatory disease states such as the inflammatory reaction induced by endotoxin or inflammatory bowel disease
04/04/2000US6046205 For treatment of venous insufficiency and of associated disorders, and also in the treatment of migraine
04/04/2000US6046191 Combination
04/04/2000US6046138 For inducing root formation in a broad range of plants; efficiency
04/04/2000US6045586 Improving the sun protection factor (spf) of textile fibre by treating with 1,3,5-triazine derivatives of given formula
04/04/2000CA1340949C Imidazole compounds and biocidal composition comprising the same for controlling harmful organisms
03/2000
03/30/2000WO2000017194A1 1-alkyl-4-[(3-oxetanyl-)benzoyl]-5-hydroxypyrazole compounds and their use as herbicides
03/30/2000WO2000017184A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000WO2000017182A1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
03/30/2000WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/30/2000WO2000017162A1 Novel thiol derivatives, process for producing the same and utilization thereof
03/30/2000WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/30/2000WO2000016603A2 Bridged heterocyclic derivatives
03/30/2000DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments
03/30/2000CA2345311A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000CA2344412A1 Thiol compound, their production and use
03/30/2000CA2344376A1 Bridged heterocyclic derivatives
03/30/2000CA2343645A1 Process for obtaining hmg-coa reductase inhibitors of high purity
03/30/2000CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/30/2000CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/29/2000EP0989114A1 N,n-disubstituted amic acid derivatives
03/29/2000EP0988301A1 Imidazolyl-cyclic acetals
03/29/2000EP0988299A1 Polymerisable, optically active dioxolane diesters
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988292A2 Piperazine derivatives and their use as anti-inflammatory agents
03/29/2000EP0988289A2 Heterocyclic compounds, their production and use
03/29/2000EP0988287A1 Method for producing nitroguanidine derivatives
03/29/2000EP0988286A1 2-fluoro-3-(1-fluoro-alkyl)-pyridine-6-yl derivatives and the use thereof in liquid crystal mixtures
03/29/2000EP0988038A1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
03/29/2000EP0988035A1 Caspases and apoptosis
03/29/2000EP0739343B1 Water soluble onium salt of taxo-diterpenoid
1 ... 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 ... 694